1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015" provides an overview of Contrast Induced Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Contrast Induced Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Contrast Induced Nephropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Contrast Induced Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Contrast Induced Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Contrast Induced Nephropathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Contrast Induced Nephropathy Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
General Electric Company 32
Clinical Trial Overview of General Electric Company 32
Cumberland Pharmaceuticals, Inc. 33
Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 33
Noorik Biopharmaceuticals AG 34
Clinical Trial Overview of Noorik Biopharmaceuticals AG 34
Ischemix 35
Clinical Trial Overview of Ischemix 35
Inotek Pharmaceuticals Corporation 36
Clinical Trial Overview of Inotek Pharmaceuticals Corporation 36
Highmark Inc. 37
Clinical Trial Overview of Highmark Inc. 37
CorMedix, Inc. 38
Clinical Trial Overview of CorMedix, Inc. 38
CareGroup, Inc. 39
Clinical Trial Overview of CareGroup, Inc. 39
Baxter International Inc. 40
Clinical Trial Overview of Baxter International Inc. 40
Alberta Innovates- Health Solutions 41
Clinical Trial Overview of Alberta Innovates- Health Solutions 41
Clinical Trial Overview of Top Institutes / Government 42
Leiden University Medical Center 42
Clinical Trial Overview of Leiden University Medical Center 42
Ospedale Misericordia e Dolce 43
Clinical Trial Overview of Ospedale Misericordia e Dolce 43
Seoul National University Hospital 44
Clinical Trial Overview of Seoul National University Hospital 44
Tehran University of Medical Sciences 45
Clinical Trial Overview of Tehran University of Medical Sciences 45
Osaka General Medical Center 46
Clinical Trial Overview of Osaka General Medical Center 46
Qom University of Medical Science and Health Services 47
Clinical Trial Overview of Qom University of Medical Science and Health Services 47
Shiraz University of Medical Sciences 48
Clinical Trial Overview of Shiraz University of Medical Sciences 48
Academic Medical Center 49
Clinical Trial Overview of Academic Medical Center 49
Addenbrooke's Hospital 50
Clinical Trial Overview of Addenbrooke's Hospital 50
Austin Health 51
Clinical Trial Overview of Austin Health 51
Five Key Clinical Profiles 52
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74

List of Tables
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Contrast Induced Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Contrast Induced Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Contrast Induced Nephropathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Contrast Induced Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Contrast Induced Nephropathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Contrast Induced Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Contrast Induced Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Contrast Induced Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Contrast Induced Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Contrast Induced Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Contrast Induced Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Contrast Induced Nephropathy Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Contrast Induced Nephropathy Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Contrast Induced Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by General Electric Company, 2015* 32
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015* 33
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Noorik Biopharmaceuticals AG, 2015* 34
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ischemix, 2015* 35
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Inotek Pharmaceuticals Corporation, 2015* 36
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Highmark Inc., 2015* 37
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by CorMedix, Inc., 2015* 38
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by CareGroup, Inc., 2015* 39
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 40
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Innovates- Health Solutions, 2015* 41
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 42
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Misericordia e Dolce, 2015* 43
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 44
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 45
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka General Medical Center, 2015* 46
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Qom University of Medical Science and Health Services, 2015* 47
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 48
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 49
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2015* 50
Contrast Induced Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 51

List of Figures
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Contrast Induced Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Contrast Induced Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Contrast Induced Nephropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Contrast Induced Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Contrast Induced Nephropathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Contrast Induced Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Contrast Induced Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Contrast Induced Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Contrast Induced Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Contrast Induced Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Contrast Induced Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Contrast Induced Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Contrast Induced Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Contrast Induced Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.